Podcast Episodes
Back to Search
Uli Stilz: Conquering Complex Diseases Affecting Billions with Precision Medicine
Episode 12
The sage-like Uli Stilz, PhD, Vice President of Novo Nordisk, provides insight into the inner workings of Novo Nordisk’s Bio Innovation Hub, which he…
1 year, 7 months ago
Tomasz (Tom) Beer: Detecting Cancer Before Symptoms? MCED Leads the Way
Episode 11
Despite advances in screening, only one in six U.S. cancers is detected early. Tomasz (Tom) Beer, MD, left most of his clinical practice to join Exac…
1 year, 7 months ago
Katy Rezvani: Allogeneic NK Cells Are Coming to Beat Cancer at a Clinic Near You
Episode 10
Katy Rezvani, MD, PhD, turned her fascination with immunology into a career engineering allogeneic immune cell therapies. On Behind the Breakthroughs…
1 year, 8 months ago
Toby Ferguson: From Bloodstream to Brain: Accessing the Neurogenetic Medicine Revolution
Episode 9
"Are we close to curing diseases like ALS and Alzheimer's?" In recent years, several academic and industry endeavors have given reason to be hopeful.…
1 year, 8 months ago
Tomi Pastinen: Treating All the Not-So-Rare “Rare Disease” Patients at Major Care Centers
Episode 8
Tomi Pastinen, MD, PhD, is transforming pediatric medicine through genomics. As Director at Children’s Mercy Kansas City, he’s pioneered pharmacogene…
1 year, 9 months ago
Tom Whitehead: Not All Precision Medicine Heroes Wear Lab Coats
Episode 7
Tom Whitehead, father of Emily Whitehead—the first pediatric CAR T patient—turned a harrowing journey into a mission to help families navigating life…
1 year, 9 months ago
Harry Clifford: Carrying Medicine Into the Post-Moore’s Law Era
Episode 6
Harry Clifford, PhD, Digital Biology Lead at NVIDIA, discusses how the computer manufacturing and AI computing leader is building a technology platfo…
1 year, 10 months ago
Michael Severino: Towards In Vivo Genome Editing of Humans
Episode 5
Michael Severino, MD, discusses the approaches for developing "genome writers" at Tessera Therapeutics, where he joined as CEO in 2022, and the advan…
1 year, 10 months ago
Jane Gibson: AMP and Molecular Diagnostics’ Existential Crisis
Episode 4
This special edition episode for the upcoming Association for Molecular Pathology (AMP) annual meeting in Vancouver, Jane Gibson, PhD, opens up the d…
1 year, 10 months ago
Helen Sabzevari: How to Turn $1,000,000 CAR Ts into “Real” Precision Medicines
Episode 3
Helen Sabzevari, PhD, President and CEO of Precigen, discusses the barriers to implementing cell and gene therapies that impede the accessibility and…
1 year, 11 months ago